SARS-CoV-2, human, 2023, Italy, clade GRA, lineage XBB.1.16, Omicron (XBB.1.16-like), strain hCoV-19/Italy/LAZ-INMI-5327/2023, VOI GRA (XBB.1.16+XBB.1.16.*) first detected in India
Product Description
Ref-SKU:
008V-05664 Infectious cell culture supernatant containing SARS-CoV-2, VOI GRA (XBB.1.16+XBB.1.16.*) first detected in India, strain hCoV-19/Italy/LAZ-INMI-5327/2023, A27S, D405N, D614G, D796Y, E180V, E484A, F486P, F490S, G142D, G252V, G339H, G446S, H146Q, H655Y, K417N, L24del, L368I, N440K, N460K, N679K, N764K, N969K, P25del, P26del, P681H, Q183E, Q954H, R346T, R408S, S371F, S373P, S375F, S477N, T19I, T376A, T478R, V213E, V445P, Y144del (S), clade GRA. This strain is preserved under Viral Storage Medium -80C. To confirm its identity the virus has been completely sequenced. Import permit can be needed in your country. If yes, please indicate it in your online enquiry.
Product Risk Group:
ICTV Taxonomy:
Virus name:
Strain:
Genotype:
Variant:
Storage conditions:
Viral Storage Medium -80C
Sequencing:
Complete genome
Infectivity:
Infectivity tested and quantified
Mycoplasmic content:
Mycoplasma free
GMO:
No
Virus host type:
Infectivity Test:
Limiting dilution assay, by determining tissue culture infectious dose (TCID50) with the method of Reed & Muench
Production cell line:
Genbank reference:
Virus Cultivability:
Passage:
1P
Identification technique:
PCR, sequencing technology (Ion Torrent), assembly method (RECoVERY 4.0)
Technical recommendation:
Culture conditions: 37°C and 5% CO2. Culture Medium: Minimum Essential Medium Eagle supplemented with 2 % heat-inactivated FBS and 1 % L-Glutamine
Shipping conditions:
IATA Classification:
Information about the collection of the virus
Recombinant product:
No
Biological material origin:
Natural origin
Collection date:
Monday, 24 April, 2023
Country of collection:
Isolation host:
Isolation technique:
cell culture